Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Ouabain Octahydrate | 11018-89-6 | sc-201548 sc-201548A | 1 g 5 g | $190.00 $720.00 | 11 | |
Ouabain is another cardiac glycoside that inhibits Na+/K+-ATPase activity and affects ion transport. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
12β-Hydroxydigitoxin is a well-known cardiac glycoside that inhibits Na+/K+-ATPase activity, leading to increased intracellular sodium levels and altered ion transport. | ||||||
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $254.00 $209.00 $311.00 $1520.00 $3014.00 $7487.00 | 1 | |
Aldosterone regulates Na+/K+-ATPase expression and activity, potentially influencing FXYD6. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Cortisol can influence electrolyte balance and Na+/K+-ATPase activity, possibly impacting FXYD6 function. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin can modulate Na+/K+-ATPase activity, which might indirectly affect FXYD6's role. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can influence Na+/K+-ATPase activity, potentially affecting FXYD6 function. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $50.00 $75.00 $260.00 $505.00 | 3 | |
Angiotensin II, through its regulatory effects on electrolyte balance, can influence Na+/K+-ATPase and potentially FXYD6. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $53.00 | ||
ATP is the primary energy source for Na+/K+-ATPase, and its availability can indirectly influence FXYD6 function. |